Aspen Pharmacare Limited (APNHY)

PNK: APNHY · Real-Time Price · USD

6.76

0.76 (12.67%)

At close: May 02, 2025, 3:19 PM

Aspen Pharmacare Income Statement

Financials in ZAR. Fiscal year is July - June.

Fiscal Year	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016
Revenue	44.71B	42.7B	40.71B	38.38B	38.61B	28.95B	28.2B	38.86B	36.21B	35.18B	37.08B	36.68B	38.31B	40.92B	41.21B	37.9B
Cost of Revenue	25.29B	23.42B	21.77B	20.77B	20.85B	15.53B	15.04B	20.41B	18.19B	17.51B	18.16B	17.38B	18.63B	20.49B	21.33B	19.3B
Gross Profit	19.42B	19.28B	18.93B	17.6B	17.76B	13.42B	13.15B	18.46B	18.02B	17.67B	18.92B	19.3B	19.68B	20.43B	19.88B	18.6B
Operating Income	7B	8.66B	9.51B	8.73B	9.22B	7.65B	7.51B	9.87B	8.24B	7.46B	8.52B	8.84B	9.4B	9.85B	9.75B	8.7B
Interest Income	468M	933M	529M	64M	n/a	262M	262M	n/a	-63M	-63M	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	5.71B	6.17B	6.55B	7.24B	8.13B	5.78B	4.41B	5.46B	4.98B	1.65B	2.53B	5.92B	6.74B	6.92B	6.25B	5B
Net Income	4.4B	4.87B	5.23B	5.8B	6.49B	4.62B	3.52B	4.44B	4.82B	1.81B	1.86B	4.89B	5.62B	5.74B	5.13B	3.7B
Selling & General & Admin	10.14B	9.8B	9.43B	8.87B	8.54B	6.54B	6.42B	8.59B	8.83B	9.27B	9.67B	9.57B	9.57B	9.79B	9.48B	9.1B
Research & Development	162M	107M	107M	216.5M	216.5M	n/a	n/a	n/a	n/a	105.5M	105.5M	111M	111M	188M	188M	200M
Other Expenses	2.12B	814M	-3.92B	-8.1B	-8.83B	-4.65B	-5.14B	-10.28B	-4.2B	-3.76B	-15.6B	-21.79B	-21.45B	-21.1B	-22.3B	-23.5B
Operating Expenses	12.42B	10.62B	9.43B	8.87B	8.54B	6.73B	6.61B	8.59B	9.78B	10.21B	10.44B	11.36B	10.91B	11.77B	11.65B	11.4B
Interest Expense	959M	1.79B	1.16B	520.25M	492.5M	301.25M	394.5M	789M	1.08B	1.27B	1.73B	2.29B	2.25B	2.2B	2.1B	2B
Selling & Marketing Expenses	6.47B	4.59B	2.89B	2.82B	2.76B	2.82B	2.89B	2.66B	4.05B	4.26B	4.71B	6.62B	6.6B	6.78B	6.72B	6.4B
Cost & Expenses	37.71B	34.04B	31.2B	29.65B	29.39B	22.26B	21.66B	29B	27.97B	27.72B	28.6B	28.75B	29.54B	32.26B	32.98B	30.7B
Income Tax Expense	1.31B	1.3B	1.33B	1.44B	1.65B	1.16B	868.5M	1B	925M	644M	724M	1.02B	1.12B	1.17B	1.12B	1.3B
Shares Outstanding (Basic)	444.12M	444.32M	444.24M	444.2M	450.7M	456.5M	456.5M	456.5M	455.52M	456.5M	455.8M	456.52M	456.63M	456.48M	461.15M	456.3M
Shares Outstanding (Diluted)	444.1M	444.3M	444.24M	444.2M	450.7M	456.5M	456.5M	456.5M	455.52M	456.5M	455.8M	456.48M	456.4M	456.45M	456.5M	456.3M
EPS (Basic)	9.92	10.96	11.77	12.96	14.30	12.08	9.66	9.75	8.92	2.31	4.08	10.72	12.32	12.52	11.18	8.12
EPS (Diluted)	9.92	10.96	11.77	12.96	14.30	12.08	9.66	9.75	8.92	2.31	4.08	10.72	12.32	12.58	11.24	8.12
EBITDA	10.3B	9.88B	10.19B	9.81B	10.46B	8.34B	7.29B	8.58B	8.03B	4.82B	10.48B	18.89B	19.93B	19.51B	19B	16.61B
EBIT	8.89B	8.53B	8.93B	8.09B	8.75B	8.23B	7.19B	6.9B	6.46B	3.5B	9.37B	17.02B	18.88B	18.4B	16.4B	14.21B
Depreciation & Amortization	1.41B	1.87B	1.79B	1.72B	1.71B	973M	955M	1.68B	1.57B	1.31B	1.19B	1.19B	1.15B	1.04B	1.08B	1B